Bristol Myers Squibb And The New Wave Of Cancer Drugs | Latest News RSS feed

Bristol Myers Squibb And The New Wave Of Cancer Drugs - Latest News

Bristol Myers Squibb And The New Wave Of Cancer Drugs

Even with the best cancer drugs, doctors are forced to switch from one therapy to the next as the tumors rapidly develop resistance. A new wave of immunotherapy drugs, in the spotlight of the upcoming ... read more

Bristol-Myers Squibb Wins U.S. Approval for Melanoma Drug

Bristol-Myers Squibb ... beginning of a new wave of treatments that spur the immune system against cancer. Bristol-Myers will be combining Yervoy with other treatments in trials to improve its ... read more

FDA approves new Bristol-Myers treatment for multiple myeloma

(Reuters) - The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for ... leader among drugmakers racing to develop a new ... read more

Looking for another news?

Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave

In the world of cancer drugs, calling a ... and Eli Lilly ($LLY) and Bristol-Myers Squibb's ($BMY) Erbitux--at least so far. After a period of less-than-impressive growth from new launches from 2005 ... read more

Bristol's drug pricing under fire as UK agency rejects Opdivo

London: Bristol-Myers Squibb's closely watched new drug Opdivo, one of the first of a new wave of cancer medicines that boost the immune system, has been rejected as too expensive for treating lung ... read more

Bristol-Myers Will Divest Celgene Blockbuster to Close Deal

Its new target is the end of 2019 or early 2020, pushed back from a previous goal of Sept. 30. The FTC review is ongoing, the company said, and European regulators will review it as well. ... read more

Bristol cancer, clot drugs drive profit beat, shares rise

Oct 27 (Reuters) - Bristol-Myers Squibb ... drug, hepatitis C treatments and its Eliquis blood clot preventer. Company shares rose 1.9 percent in premarket trading. Bristol-Myers is considered the ... read more

Bristol-Myers Squibb's Opdivo misses its shot at earlier use in liver cancer

Bristol-Myers Squibb’s Opdivo already boasts an FDA approval in liver cancer patients who have been treated with Bayer’s Nexavar. But its quest to jump into the front line just hit a snag. The BMS ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us